Journal
MUCOSAL IMMUNOLOGY
Volume 14, Issue 3, Pages 547-554Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/s41385-020-00365-4
Keywords
-
Categories
Funding
- European Research Council (ERC) under the European Union [788191-Homo.symbiosus]
Ask authors/readers for more resources
Humans share a core intestinal microbiome but differ in genes, species, enterotypes, and gene count. Microbiome gene count is a key factor for health in immune disorders and clinical conditions. Metagenomic analysis helps define the host-microbe symbiosis associated with a healthy status, and disruption of this symbiosis may lead to chronic diseases or iatrogenic conditions. Möglichkeiten zur Anwendung einer Mikrobiota-Modulation für personalisierte Ernährung und Therapie zur Erhaltung, Konservierung oder Wiederherstellung der Gast-Mikrobe-Symbiose werden diskutiert.
Humans share a core intestinal microbiome and yet human microbiome differs by genes, species, enterotypes (ecology), and gene count (microbial diversity). Achievement of microbiota metagenomic analysis has revealed that the microbiome gene count is a key stratifier of health in several immune disorders and clinical conditions. We review here the progress of the metagenomic pipeline analysis, and how this has allowed us to define the host-microbe symbiosis associated with a healthy status. The link between host-microbe symbiosis disruption, the so-called dysbiosis and chronic diseases or iatrogenic conditions is highlighted. Finally, opportunities to use microbiota modulation, with specific nutrients and/or live microbes, as a target for personalized nutrition and therapy for the maintenance, preservation, or restoration of host-microbe symbiosis are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available